EEF1A1P28

Across TCGA pan-cancer cohorts, EEF1A1P28 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated EEF1A1P28 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher EEF1A1P28 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated EEF1A1P28 expression acts as an unfavorable survival marker, although some lineages such as READ and KIRC show a favorable association.

READ, KIRC, and PAAD are the cancer types where EEF1A1P28 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Median	All	0.744	0.331	<.001	106	view →
KIRC	OS	Tertile	All	0.741	0.533	<.001	56	view →
PAAD	OS	Quartile	All	0.364	0.619	.006	48	view →
OV	OS	Quartile	All	0.227	0.355	.004	36	view →
UCS	OS	Median	IV	0.732	0.224	.018	36	view →
SKCM	OS	Median	All	0.924	0.813	.003	30	view →
BLCA	OS	Median	III,IV	0.261	0.513	.001	24	view →
KICH	DFS	Quartile	All	0.683	1.000	.033	20	view →
ACC	DFS	Median	All	0.324	0.585	.009	16	view →
MESO	DFS	Median	IV	0.454	0.201	.027	15	view →
LUSC	OS	Tertile	II,III,IV	0.732	0.560	.013	14	view →
GBM	DFS	Quartile	All	0.295	0.176	.015	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

EEF1A1P28–READ (DFS)

Open the READ breakdown →